All In MedTech

Company

Lutonix

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$10.0M

1 Form D offering, 2010 to 2010

Equity

$10.0M

Stock sold for cash

Debt and convertible notes

$0

Loans and notes sold to investors

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $10.0M raised of $45.0M sought, first sale Dec 1, 2010, 23 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Dec 1, 2010Equity$10.0M$45.0M23Rule 506Form D ↗Dec 13, 2010

Company details

From the company's latest Form D.

Legal name
LUTONIX INC
Headquarters
Maple Grove, Minnesota
Incorporated
Delaware in 2007
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    12 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Lutonix.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    No device trials list this company as lead sponsor.

    Reports received

    56

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    42

    75% of reports

    Injury reports

    14

    25% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 231300
    Jan 245200
    Feb 241200
    Mar 241400
    Apr 240900
    May 240120
    Jun 245300
    Jul 245400
    Aug 246700
    Sep 241500
    Oct 246900
    Nov 2411000
    Dec 242200
    Jan 253200
    Feb 251510
    Mar 255420
    Apr 252700
    May 251400
    Jun 251200
    Jul 2511700
    Aug 254500
    Sep 256410
    Oct 251200
    Nov 256100
    Dec 252400
    Jan 264100
    Feb 268100
    Mar 267000
    Apr 263100
    May 262300
    Jun 263100
    Jul 263100
    Aug 261000
    Sep 261000
    Oct 262100
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.